Grapefruit is a Intradermal; Percutaneous; Subcutaneous Solution in the Non-standardized Allergenic category. It is labeled and distributed by Greer Laboratories, Inc.. The primary component is Grapefruit.
Product ID | 22840-5725_79ebe8af-3396-1b14-e053-2a91aa0a89ba |
NDC | 22840-5725 |
Product Type | Non-standardized Allergenic |
Proprietary Name | Grapefruit |
Generic Name | Citrus X Paradisi |
Dosage Form | Solution |
Route of Administration | INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS |
Marketing Start Date | 1981-09-15 |
Marketing Category | BLA / BLA |
Application Number | BLA101833 |
Labeler Name | Greer Laboratories, Inc. |
Substance Name | GRAPEFRUIT |
Active Ingredient Strength | 0 g/mL |
Pharm Classes | Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Fruit Proteins [EXT] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 1981-09-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA101833 |
Product Type | NON-STANDARDIZED ALLERGENIC |
Marketing Start Date | 1981-09-15 |
Marketing Category | BLA |
Application Number | BLA101833 |
Product Type | NON-STANDARDIZED ALLERGENIC |
Marketing Start Date | 1981-09-15 |
Ingredient | Strength |
---|---|
GRAPEFRUIT | .025 g/mL |
NDC | Brand Name | Generic Name |
---|---|---|
0268-6141 | GRAPEFRUIT | Grapefruit |
22840-5725 | Grapefruit | Citrus X paradisi |
36987-1330 | Grapefruit | Grapefruit |
36987-1331 | Grapefruit | Grapefruit |
36987-1332 | Grapefruit | Grapefruit |
36987-1333 | Grapefruit | Grapefruit |
49288-0222 | Grapefruit | Grapefruit |
49288-0223 | Grapefruit | Grapefruit |
54575-399 | GRAPEFRUIT | grapefruit |
76150-204 | Grapefruit | Sunscreen |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
GRAPEFRUIT 97200860 not registered Live/Pending |
Grapefruit Testing LLC 2022-01-03 |
GRAPEFRUIT 87932076 not registered Live/Pending |
Espro, Inc. 2018-05-22 |